论文部分内容阅读
目的:观察前痛定方对Ⅲb型前列腺炎患者尿流率-尿道括约肌肌电图的影响。方法:将120例患者采用区组随机化方法分为为G1、G2和G3组。G1组口服前痛定方;G2组口服盐酸坦索罗辛缓释胶囊;G3组口服前痛定方联合盐酸坦索罗辛缓释胶囊,疗程均为6周。治疗前后对所有患者进行前列腺症状评分(NIH-CPSI)及尿流率-尿道括约肌肌电图检测。结果:治疗前3组间基线特征均衡性良好(P>0.05);治疗后3组患者的最大尿流率(Qmax)、平均尿流率(Qave)及肌电图比值(TL值)均有显著提高(P<0.05),NIH-CPSI评分明显降低(P<0.05);其中G3组的作用效果明显要优于G1、G2组(P<0.05)。结论:前痛定方联合盐酸坦索罗辛缓释胶囊可以显著改善Ⅲb型前列腺炎患者的下尿路功能性梗阻,从而提高Ⅲb型前列腺炎患者的生活质量。
Objective: To observe the effect of QianTongDingFang on urinary flow rate in patients with type Ⅲb prostatitis - urethral sphincter electromyography. Methods: One hundred and twenty patients were divided into G1, G2 and G3 groups by block randomization method. G1 group before oral administration of tamsulosin; G2 group oral tamsulosin hydrochloride sustained release capsules; G3 group before oral administration of analgesic tamsulosin hydrochloride sustained release capsules, treatment for 6 weeks. Prostate symptom score (NIH-CPSI) and urinary flow-urethral sphincter electromyography were measured in all patients before and after treatment. Results: The baseline characteristics of the three groups were well balanced before treatment (P> 0.05). The Qmax, Qave and TL of the three groups after treatment were (P <0.05), NIH-CPSI score was significantly lower (P <0.05). The effect of G3 group was better than that of G1 and G2 group (P <0.05). Conclusion: The combination of QianTongDingFang and tamsulosin hydrochloride sustained release capsules can significantly improve the lower urinary tract obstruction in patients with type Ⅲb prostatitis, and thus improve the quality of life of type Ⅲb prostatitis patients.